Oligonucleotide-based therapeutics (ONs) are a relatively new class of drugs that represent one of the most prominent fields of drug discovery and development. They have the potential to treat or manage a wide range of diseases, while they can be applied in numerous therapeutic and biotechnology applications.
Understanding biosimilar drugs: what are their key characteristics and how do they differ from generic drugs?
Bile acids are amphiphilic molecules, naturally produced in humans, that demonstrate unique physicochemical properties and provide multiple health benefits.
We join the fight against COVID-19 by offering SBE-β-CD: the critical excipient that improves the efficacy of remdesivir
Pharmaceutical process technology and IP: is "out-of-the-box" thinking enough to drive your business forward?